Viewing Study NCT04556292


Ignite Creation Date: 2025-12-24 @ 3:29 PM
Ignite Modification Date: 2026-01-26 @ 3:05 AM
Study NCT ID: NCT04556292
Status: UNKNOWN
Last Update Posted: 2020-09-21
First Post: 2020-09-15
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study to Assess the Efficacy and Safety of SC10914 in the Metastatic Breast Cancer Patients
Sponsor: Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer Metastatic View
None BRCA 1 Gene Mutation View
None BRCA 2 Gene Mutation View
Keywords: